[The cerebrospinal fluid concentration of lamoxactam with reference to the therapy of gram-negative CNS infections].
D000328:Adult; D000368:Aged; D001424:Bacterial Infections / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D001930:Brain Injuries / Q000150:complications; D002511:Cephalosporins / Q000134:cerebrospinal fluid*; D002513:Cephamycins / Q000134:cerebrospinal fluid* / Q000627:therapeutic use; D006801:Humans; D008581:Meningitis / Q000134:cerebrospinal fluid / Q000188:drug therapy*; D008875:Middle Aged; D009070:Moxalactam; D011183:Postoperative Complications / Q000188:drug therapy
D002511:Cephalosporins; D002513:Cephamycins; D009070:Moxalactam
Die Liquorgängigkeit von Lamoxactam unter Berücksichtigung der Therapie gramnegativer ZNS Infektionen.